Document is current
Any future updates will be listed below
-
Authors
Reed, Christopher R.
Curry, Nicola
Juffermans, Nicole P.
Neal, Matthew D.
- License Information
-
More Information
Article History
Received: 29 January 2025
Accepted: 27 September 2025
First Online: 18 October 2025
Declarations
:
: Not applicable.
: Not applicable.
: CR has no competing interests. NC has received research funding from the NIHR, Wellcome Trust, MRC, SOBI, CSL Behring, and Octapharma. She has received consulting fees from Octapharma, SOBI, LFB, CSL Behring, and Bayer. NJ reports an unrestricted investigator-initiated research grant from Octapharma on endotheliopathy. MN serves as the Chief Medical Officer for Haima Therapeutics. He has received research funding from the NIH, DoD, DARPA, Takeda, and Haemonetics. He has received consulting fees from Haemonetics, Takeda, Octapharma, and CellPhire.
